可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] 臧益民,臧伟进,王晓明. 心力衰竭的病理生理机制及治疗概述[J]. 心脏杂志, 2002, 14(5):417-419.
[2] Walsh JT, Batin PD, Hawkins M, et al. Ventricular dilatation in the absence of ACE inhibitors: influence of haemodynamic and neurohor-monal variables following myocardial infarction[J]. Heart, 1999, 81(1):33-39.
[3] Pfeffer MA, McMurray JJ, Velazquez EJ, et al. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both[J]. N Engl J Med, 2003, 349(20):1893-1906.
[4] Sandmann S, Li J, Fritzenktter C, et al. Differential effects of olmesartan and ramipril on inflammatory response after myocardial infarction in rats[J]. Blood Pressure, 2006, 15(2):116-128.
[5] Oishia Y, Ozonoa R, Yoshizumi M, et al. AT2 receptor mediates the cardioprotective effects of AT1 receptor antagonist in post-myocardial infarction remodeling[J]. Life Sci, 2006, 80(1):82-88.
[6] Korup E, Dalsgaard D, Nyvad O, et al. Comparison of degrees of left ventricular dilation with in three hours and up to six days after onset of first acute myocardial infarction[J]. Am J Cardiol, 1997, 80(4):449-453.